MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers Jan 12 • 3 min read MindMed announced an innovative randomized placebo-controlled study evaluating the effects of daytime and evening administration of low doses of LSD on cognitive performance.
Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics Jan 11 • 4 min read Cybin Inc. announced that it has entered into an agreement with neurotech pioneer HI, LLC dba Kernel.
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Jan 8 • 5 min read COMPASS Pathways plc is establishing its first Centre of Excellence in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics.
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand Jan 7 • 5 min read Mind Medicine Inc. announced that it has closed its previously announced bought deal short form prospectus offering.
Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research Jan 6 • 5 min read Mind Cure Health Inc. announced the release of iSTRYM, the company’s digital therapeutic tool.